AMERICAN CENTURY COMPANIES INC – Alnylam Pharmaceuticals, Inc. Transaction History
AMERICAN CENTURY COMPANIES INC portfolio value:
$138.71M
portfolio value
AMERICAN CENTURY COMPANIES INC quarter portfolio value change:
+37.24%
quarter
Alnylam Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +20.54% | 118.06K shares | 54.85M | $200.16 | 693.00K |
| Q2 2022 | share | Decrease | -49.20% | -556.90K shares | -100.96M | $145.85 | 574.94K |
| Q1 2022 | share | Increase | +12.89% | 129.27K shares | 14.80M | $163.29 | 1.13M |
| Q4 2021 | share | Decrease | -6.43% | -68.89K shares | -32.28M | $171.03 | 1.00M |
| Q3 2021 | share | Increase | +2.42% | 25.28K shares | 24.95M | $188.81 | 1.07M |
| Q2 2021 | share | Decrease | -4.42% | -48.33K shares | 22.81M | $169.52 | 1.04M |
| Q1 2021 | share | Increase | +1.41% | 15.17K shares | 14.25M | $141.19 | 1.09M |
| Q4 2020 | share | Increase | +9.10% | 90.03K shares | -3.76M | $129.97 | 1.07M |
| Q3 2020 | share | Decrease | -0.79% | -7.87K shares | -3.64M | $145.6 | 989.31K |
| Q2 2020 | share | Increase | +145.23% | 590.55K shares | 103.43M | $148.11 | 997.18K |
| Q1 2020 | share | Increase | +47.61% | 131.14K shares | 12.53M | $108.85 | 406.62K |
| Q4 2019 | share | Decrease | -6.16% | -18.08K shares | 8.11M | $115.17 | 275.48K |
| Q3 2019 | share | Decrease | -11.76% | -39.12K shares | -531K | $80.42 | 293.56K |
| Q2 2019 | share | Decrease | -53.20% | -378.16K shares | -42.28M | $72.56 | 332.68K |
| Q1 2019 | share | Increase | +2.55% | 17.68K shares | 15.89M | $93.45 | 710.85K |
| Q4 2018 | share | Increase | +12.67% | 77.94K shares | -3.30M | $72.91 | 693.16K |
| Q3 2018 | share | Increase | +43.83% | 187.48K shares | 11.71M | $87.52 | 615.22K |
| Q2 2018 | share | Increase | 0.00% | 427.74K shares | 42.12M | $98.49 | 427.74K |
| Q4 2017 | share | Decrease | -100.00% | -6.21K shares | -730K | $127.05 | 0 |
| Q3 2017 | share | Decrease | -35.93% | -3.48K shares | -44K | $117.49 | 6.21K |
| Q2 2017 | share | 0.00% | 0 shares | 277K | $79.76 | 9.70K | |
| Q1 2017 | share | 0.00% | 0 shares | 134K | $51.25 | 9.70K | |
| Q4 2016 | share | Decrease | -4.62% | -470 shares | -327K | $37.44 | 9.70K |
| Q3 2016 | share | Decrease | -2.12% | -220 shares | 113K | $67.78 | 10.17K |
| Q2 2016 | share | Increase | 0.00% | 10.39K shares | 577K | $55.49 | 10.39K |